sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Endocrine Disruption Screening Market Scope And Analysis

  • Report Code : TIPRE00025912
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 226
Buy Now

Endocrine Disruption Screening Market Analysis Report 2031

Buy Now

Endocrine Disruption Screening Market Report Endocrine Disruption Screening Market Size and Share Endocrine Disruption Screening Market Scope and Analysis

Endocrine Disruption Screening Market Report Scope

Report Attribute Details
Market size in 2021 US$ 126.53 Million
Market Size by 2028 US$ 153.30 Million
Global CAGR (2021 - 2028) 2.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Assay Type
  • In-Vitro and In-Vivo
By Application
  • Natural Materials and Synthetic Materials
By Sources of Waste
  • Incineration and Landfill
  • Agricultural Runoff
  • Industrial and Municipal Effluents
  • Pulp Mill Effluents
  • Consumer Products
By Method
  • Estrogen Receptor Transactivation
  • Androgen Receptor Transactivation
  • Androgen Receptor Modulation
  • Estrogen Receptor-Alpha Binding
  • Estrogen Receptor-Beta Binding
  • Androgen Receptor Binding
  • Steroidogenesis
  • Aromatase Assay
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CREATIVE BIOARRAY
  • XENOMETRIX AG
  • CHARLES RIVER
  • EUROFINS SCIENTIFIC
  • SMITHERS
  • SGS SA
  • JRF GLOBAL
  • M RIEUX NUTRISCIENCES
  • ALPHA ANALYTICAL
    		•